|
Volumn 16, Issue 17, 2008, Pages 8196-8204
|
Antibacterial profile against drug-resistant Staphylococcus epidermidis clinical strain and structure-activity relationship studies of 1H-pyrazolo[3,4-b]pyridine and thieno[2,3-b]pyridine derivatives
|
Author keywords
Antibacterial activity; Antimicrobial activity; In silico ADMET screening; MIC; Pyrazolopyridine; Staphylococcus epidermidis; Structure activity relationship (SAR)
|
Indexed keywords
1H PYRAZOLO[3,4 B]PYRIDINE;
4 (3' BROMOPHENYLAMINO) 1 PHENYL 1H PYRAZOLO[3,4 B]PYRIDINE 5 CARBOXYLIC ACID;
4 (3' BROMOPHENYLAMINO)THIENO[2,3 B]PYRIDINE 5 CARBOXYLIC ACID;
4 (3' CHLOROPHENYLAMINO) 1 PHENYL 1H PYRAZOLO[3,4 B]PYRIDINE 5 CARBOXYLIC ACID;
4 (3' CHLOROPHENYLAMINO)THIENO[2,3 B]PYRIDINE 5 CARBOXYLIC ACID;
4 (3' FLUOROPHENYLAMINO) 1 PHENYL 1H PYRAZOLO[3,4 B]PYRIDINE 5 CARBOXYLIC ACID;
4 (3' FLUOROPHENYLAMINO)THIENO[2,3 B]PYRIDINE 5 CARBOXYLIC ACID;
4 (3' METHOXYPHENYLAMINO) 1 PHENYL 1H PYRAZOLO[3,4 B]PYRIDINE 5 CARBOXYLIC ACID;
4 (3' METHOXYPHENYLAMINO)THIENO[2,3 B]PYRIDINE 5 CARBOXYLIC ACID;
4 (3' METHYLPHENYLAMINO) 1 PHENYL 1H PYRAZOLO[3,4 B]PYRIDINE 5 CARBOXYLIC ACID;
4 (3' METHYLPHENYLAMINO)THIENO[2,3 B]PYRIDINE 5 CARBOXYLIC ACID;
4 (3' NITROPHENYLAMINO) 1 PHENYL 1H PYRAZOLO[3,4 B]PYRIDINE 5 CARBOXYLIC ACID;
4 (3' NITROPHENYLAMINO)THIENO[2,3 B]PYRIDINE 5 CARBOXYLIC ACID;
4 (4' BROMOPHENYLAMINO) 1 PHENYL 1H PYRAZOLO[3,4 B]PYRIDINE 5 CARBOXYLIC ACID;
4 (4' CHLOROPHENYLAMINO) 1 PHENYL 1H PYRAZOLO[3,4 B]PYRIDINE 5 CARBOXYLIC ACID;
4 (4' FLUOROPHENYLAMINO) 1 PHENYL 1H PYRAZOLO[3,4 B]PYRIDINE 5 CARBOXYLIC ACID;
4 (4' METHOXYPHENYLAMINO) 1 PHENYL 1H PYRAZOLO[3,4 B]PYRIDINE 5 CARBOXYLIC ACID;
4 (4' METHOXYPHENYLAMINO)THIENO[2,3 B]PYRIDINE 5 CARBOXYLIC ACID;
4 (4' METHYLPHENYLAMINO) 1 PHENYL 1H PYRAZOLO[3,4 B]PYRIDINE 5 CARBOXYLIC ACID;
4 (4' NITROPHENYLAMINO) 1 PHENYL 1H-PYRAZOLO[3,4 B]PYRIDINE 5 CARBOXYLIC ACID;
4 (4' NITROPHENYLAMINO)THIENO[2,3 B]PYRIDINE 5 CARBOXYLIC ACID;
4 PHENYLAMINO 1 PHENYL 1H PYRAZOLO[3,4 B]PYRIDINE 5 CARBOXYLIC ACID;
CARBOXYLIC ACID DERIVATIVE;
CHLORAMPHENICOL;
OXACILLIN;
PYRIDINE DERIVATIVE;
THIENO[2,3 B]PYRIDINE DERIVATIVE;
UNCLASSIFIED DRUG;
ANTIBACTERIAL ACTIVITY;
ANTIBIOTIC RESISTANCE;
ARTICLE;
BACTERIAL GROWTH;
BACTERIAL STRAIN;
CONTROLLED STUDY;
CYTOTOXICITY;
DRUG SENSITIVITY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
HUMAN;
HUMAN CELL;
MINIMUM INHIBITORY CONCENTRATION;
NONHUMAN;
STAPHYLOCOCCUS EPIDERMIDIS;
STRUCTURE ACTIVITY RELATION;
SUBSTITUTION REACTION;
ANTI-BACTERIAL AGENTS;
CELL SURVIVAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG RESISTANCE, BACTERIAL;
HUMANS;
LEUKOCYTES, MONONUCLEAR;
MICROBIAL SENSITIVITY TESTS;
MODELS, MOLECULAR;
PYRAZOLES;
PYRIDINES;
REFERENCE VALUES;
STAPHYLOCOCCUS EPIDERMIDIS;
STRUCTURE-ACTIVITY RELATIONSHIP;
TIME FACTORS;
STAPHYLOCOCCUS EPIDERMIDIS;
|
EID: 50349087353
PISSN: 09680896
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmc.2008.07.035 Document Type: Article |
Times cited : (65)
|
References (25)
|